NASDAQ:BMGL Basel Medical Group (BMGL) Stock Price, News & Analysis $1.98 +0.02 (+1.02%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About Basel Medical Group Stock (NASDAQ:BMGL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Basel Medical Group alerts:Sign Up Key Stats Today's Range$1.90▼$2.0450-Day Range$1.61▼$3.6252-Week Range$0.91▼$9.40Volume51,293 shsAverage Volume3.83 million shsMarket Capitalization$36.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore. Read More Receive BMGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Basel Medical Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BMGL Stock News HeadlinesBasel Medical Group Ltd's Lock-Up Period Set To Expire on August 25th (NASDAQ:BMGL)August 18, 2025 | americanbankingnews.comBRIEF-Basel Medical Group Putting On Hold On The Acquisition Of Btc Digital AssetJuly 18, 2025 | sg.finance.yahoo.comCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.August 28 at 2:00 AM | SmartAsset (Ad)Basel Medical Group Ltd: Basel Medical Group Putting On Hold On The Acquisition of BTC Digital AssetJuly 18, 2025 | finanznachrichten.deBasel Medical Group Putting On Hold On The Acquisition of BTC Digital AssetJuly 17, 2025 | globenewswire.comBasel Medical Group News (BMGL) - Investing.comJuly 3, 2025 | investing.comBasel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund RaisingJune 26, 2025 | globenewswire.comBasel Medical Group LtdJune 21, 2025 | morningstar.comMSee More Headlines BMGL Stock Analysis - Frequently Asked Questions How have BMGL shares performed this year? Basel Medical Group's stock was trading at $4.50 at the start of the year. Since then, BMGL stock has decreased by 56.0% and is now trading at $1.98. When did Basel Medical Group IPO? Basel Medical Group (BMGL) raised $9 million in an initial public offering (IPO) on Tuesday, February 25th 2025. The company issued 2,205,000 shares at a price of $4.00 per share. When did Basel Medical Group's lock-up period expire? Basel Medical Group's lock-up period expired on Monday, August 25th. Basel Medical Group had issued 2,205,000 shares in its IPO on February 25th. The total size of the offering was $8,820,000 based on an initial share price of $4.00. Since the end of Basel Medical Group's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted. Who are Basel Medical Group's major shareholders? Top institutional shareholders of Basel Medical Group include Marex Group plc (0.08%). How do I buy shares of Basel Medical Group? Shares of BMGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today8/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNASDAQ:BMGL CIK2004489 WebN/A Phone(656) 291-9188FaxN/AEmployees36Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares18,450,000Free FloatN/AMarket Cap$36.72 million OptionableN/A BetaN/A 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:BMGL) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basel Medical Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Basel Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.